Adma Biologics Inc (NASDAQ: ADMA) Hogging The Spotlight Today
Currently, there are 226.06M common shares owned by the public and among those 225.20M shares have been available to trade. The company’s stock has a 5-day price change of 22.52% and 71.42% over the past three months. ADMA shares are trading 328.54% year to date (YTD), with the 12-month market performance up to 450.28% higher. […]
Adma Biologics Inc (NASDAQ: ADMA) Is Getting Increasingly Hard To Ignore
Currently, there are 226.06M common shares owned by the public and among those 225.20M shares have been available to trade. The company’s stock has a 5-day price change of -15.50% and 28.04% over the past three months. ADMA shares are trading 279.31% year to date (YTD), with the 12-month market performance up to 414.86% higher. […]
Adma Biologics Inc (NASDAQ: ADMA) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 226.06M common shares owned by the public and among those 225.20M shares have been available to trade. The company’s stock has a 5-day price change of 4.81% and 72.67% over the past three months. ADMA shares are trading 358.41% year to date (YTD), with the 12-month market performance up to 518.51% higher. […]
Some Investing Thoughts On Adma Biologics Inc (NASDAQ: ADMA)
Adma Biologics Inc (ADMA) concluded trading on Wednesday at a closing price of $19.50, with 3.34 million shares of worth about $65.16 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 207.09% during that period and on October 02, 2024 the price saw a […]
Adma Biologics Inc (NASDAQ: ADMA): Stock That Needs Special Handling
Currently, there are 226.06M common shares owned by the public and among those 225.18M shares have been available to trade. The company’s stock has a 5-day price change of 10.45% and 81.64% over the past three months. ADMA shares are trading 342.04% year to date (YTD), with the 12-month market performance up to 462.82% higher. […]
Uncovering Institutional Buying In Adma Biologics Inc (NASDAQ: ADMA)
BlackRock Fund Advisors recently announced the acquisition of new stake in Adma Biologics Inc (NASDAQ:ADMA). The institutional investor has increased its shareholding in the Healthcare company by 1.87% to 15.09 million shares with purchase of 0.28 million shares. This fresh investment now brings its stake to 6.68% valued currently at $55.84 million. In addition, The […]
Adma Biologics Inc (NASDAQ: ADMA): Reassessing Prospects
Adma Biologics Inc (ADMA) concluded trading on 12/28/23 at a closing price of $4.52, with 4.18 million shares of worth about $18.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 24.52% during that period and on Thursday the price saw a gain of […]
